改善缺血性中风后功能性结果预测的生物标志物:来自SICFAIL,STRAWINSKI和PREDICT研究的结果
Felipe A Montellano1,2,3, Viktoria Rücker1, Kathrin Ungethüm1,4
1Institute of Clinical Epidemiology and Biometry, Julius-Maximilians-Universität (JMU) Würzburg, Würzburg, Germany.
European stroke journal
|May 7, 2024
概括
像copeptin这样的生物标志物可以提高急性缺血性中风 (AIS) 的预测结果,如果添加到现有的得分. 这些标记物提高了AIS患者的预后模型的准确性.
科学领域:
- 神经学 神经学
- 生物标志物 生物标志物
- 临床预测 临床预测
背景情况:
- 对急性缺血性中风 (AIS) 的准确预测结果至关重要,但具有挑战性.
- 现有的AIS预测模型在预测性能方面存在局限性.
研究的目的:
- 评估一个由五个生物标志物组成的小组是否可以提高AIS的确定的预后得分的预测准确性.
- 评估生物标志物对AIS预后模型歧视,校准和整体性能的影响.
主要方法:
- 利用了两个前性队列研究 (SICFAIL,PREDICT) 和一个临床试验 (STRAWINSKI) 的数据.
- 研究了五种生物标志物:普罗卡尔西托尼,科佩丁,皮质醇,中区域前性尿素 (MR-proANP) 和N终端前B型尿素 (NT-proBNP).
- 通过添加预测不良结果的生物标志物 (mRS > 2) 来评估ASTRAL和年龄/NIHSS分数的性能提升.
主要成果:
- 素,NT-proBNP和MR-proANP显著改善了ASTRAL得分在衍生数据集中的表现.
- 在验证数据集中,可佩因独立与不良结果和死亡率有关.
- 虽然copeptin没有增强验证中的歧视,但它改善了校准和整体模型性能.
结论:
- 生物标志物,特别是素,NT-proBNP和MR-proANP,在预测AIS结果方面提供了适度但一致的改进.
- 科佩与中度至重度AIS的不良结果有着一致的关联,尽管它的附加值需要进一步评估.
更多相关视频
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
141
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
141
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
80
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
80